Abstract
Amyotrophic lateral sclerosis (ALS) is the most frequent degenerative disease affecting motor neurons (MN). ALS has been traditionally considered as a pure motor system disease; however, there are currently sufficient evidences supporting the involvement of other non-motor systems. Recently, the development and the implementation of the optical coherence tomography (OCT) have provided new data regarding the ocular involvement in the disease. In this sense, alterations in retinal nerve fiber layer thickness (RNFL), other retinal layers thicknesses such as outer nuclear layer (ONL) and inner nuclear layer (INL) and changes in the retinal blood vessels have been described in ALS patients. Interestingly, the study of ocular alterations in ALS appears not only as new biomarker tool, but also as a new opportunity to deep into the pathogenesis of the disease. In this article we will review and standardize published studies regarding OCT and ALS, emphasizing both their strengths and weaknesses.
Similar content being viewed by others
References
Riancho J, Lozano-Cuesta P, Santurtun A, Sanchez-Juan P, Lopez-Vega JM, Berciano J et al (2016) Amyotrophic lateral sclerosis in northern Spain 40 years later: what has changed? Neurodegener Dis 16(5–6):337–341
Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R et al (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol 142:104–129
Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Munain AL, Santurtun A (2018) The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol 62(8):1361–1374
Riancho J, Gil-Bea FJ, Santurtun A, Lopez DM (2019) Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach. Neural Regener Res 14(2):193–196
Hoon M, Okawa H, Della SL, Wong RO (2014) Functional architecture of the retina: development and disease. Prog Retin Eye Res 42:44–84
Liu Z, Wang H, Fan D, Wang W (2018) Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis. J Clin Neurosci 48:233–237
Ringelstein M, Albrecht P, Sudmeyer M, Harmel J, Muller AK, Keser N et al (2014) Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(4):290–297
Hubers A, Muller HP, Dreyhaupt J, Bohm K, Lauda F, Tumani H et al (2016) Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J Neural Transm (Vienna ) 123(3):281–287
Simonett JM, Huang R, Siddique N, Farsiu S, Siddique T, Volpe NJ et al (2016) Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep 6:29187
Mukherjee N, McBurney-Lin S, Kuo A, Bedlack R, Tseng H (2017) Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS ONE 12(9):e0185242
Rohani M, Meysamie A, Zamani B, Sowlat MM, Akhoundi FH (2018) Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J Neurol 265(7):1557–1562
Abdelhak A, Hubers A, Bohm K, Ludolph AC, Kassubek J, Pinkhardt EH (2018) In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J Neurol 265(4):949–953
Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ et al (2013) Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 20(8):1170–1176
Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V (2013) The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 55:62–76
Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436–1441
Toth RP, Atkin JD (2018) Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol 9:1017
Riancho J, Gonzalo I, Ruiz-Soto M, Berciano J (2019) Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. Neurologia 34(1):27–37
Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P et al (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 78(7):754–756
Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer's disease and other neurodegenerative diseases. Front Neurol 8:701
Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40–49
Manogaran P, Hanson JV, Olbert ED, Egger C, Wicki C, Gerth-Kahlert C et al (2016) Optical coherence tomography and magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Int J Mol Sci 17(11):1894
Eraslan M, Balci SY, Cerman E, Temel A, Suer D, Elmaci NT (2016) Comparison of optical coherence tomography findings in patients with primary open-angle glaucoma and Parkinson disease. J Glaucoma 25(7):e639–e646
Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M et al (2012) Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 314(1–2):97–101
Casado A, Cervero A, Lopez-de-Eguileta A, Fernandez R, Fonseca S, Gonzalez JC et al (2019) Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects. PLoS ONE 14(9):e0222347
Lopez-de-Eguileta A, Lage C, Lopez-Garcia S, Pozueta A, Garcia-Martinez M, Kazimierczak M et al (2019) Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET. Alzheimers Dement (NY) 5:570–578
Cabrera DD, Somfai GM, Koller A (2017) Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol 312(2):H201–H212
Liew G, Wang JJ, Mitchell P, Wong TY (2008) Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging 1(2):156–161
Buckley AF, Bossen EH (2013) Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J Neuropathol Exp Neurol 72(10):906–918
Kolde G, Bachus R, Ludolph AC (1996) Skin involvement in amyotrophic lateral sclerosis. Lancet 347(9010):1226–1227
Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akidan M et al (2018) Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia. Br J Ophthalmol 102(2):233–237
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Cerveró, A., Casado, A. & Riancho, J. Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window. J Neurol 268, 2083–2089 (2021). https://doi.org/10.1007/s00415-019-09654-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09654-w